Yukiko Noguchi Selected Research

Melanoma (Melanoma, Malignant)

11/2004	Pharmacological characterization of YM598, a selective endothelin-A receptor antagonist.
9/2004	Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yukiko Noguchi Research Topics

Disease

5	Overactive Urinary Bladder (Overactive Bladder) 08/2009 - 04/2005
4	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2010 - 06/2006
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/2019 - 02/2008
2	Urologic Diseases (Urinary Tract Disease) 06/2019 - 03/2019
2	Lower Urinary Tract Symptoms 01/2018 - 09/2006
2	Carcinoma (Carcinomatosis) 05/2016 - 01/2016
2	Melanoma (Melanoma, Malignant) 11/2004 - 09/2004
1	Birth Weight (Birth Weights) 04/2020
1	Hyperplasia 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2016
1	Neoplasms (Cancer) 01/2016
1	Cognitive Dysfunction 02/2007
1	Cerebral Infarction 02/2007
1	Infarction (Infarctions) 02/2007
1	Urge Urinary Incontinence (Urge Incontinence) 01/2007
1	Mydriasis 02/2006
1	Miosis 02/2006
1	Pulmonary Hypertension 06/2005
1	Hypoxia (Hypoxemia) 06/2005
1	Right Ventricular Hypertrophy 06/2005
1	Urinary Retention 04/2005

Drug/Important Bio-Agent (IBA)

5	Solifenacin Succinate FDA Link 08/2009 - 04/2005
4	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 08/2009 - 01/2007
4	Endothelins (Endothelin)IBA 06/2006 - 09/2004
3	Tamsulosin (Flomax)FDA LinkGeneric 01/2010 - 02/2006
3	N- (6- methoxy- 5- (2- methoxyphenoxy)- 2- (pyrimidin- 2- yl)pyrimidin- 4- yl)- 2- phenylethenesulfonamide (YM598)IBA 06/2005 - 09/2004
2	ASP6432IBA 06/2019 - 03/2019
2	Muscarinic AntagonistsIBA 02/2007 - 01/2007
2	Bosentan (Tracleer)FDA Link 11/2004 - 09/2004
2	AtrasentanIBA 11/2004 - 09/2004
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 05/2016
1	Interleukin-6 (Interleukin 6)IBA 05/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Biological ProductsIBA 01/2016
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2008
1	Tolterodine Tartrate (Detrol)FDA Link 02/2007
1	Cholinergic Antagonists (Anticholinergics)IBA 02/2007
1	darifenacin FDA Link 02/2007
1	salicylhydroxamic acid (SHAM)IBA 02/2007
1	Scopolamine (Hyoscine)FDA Link 02/2007
1	G 1617IBA 01/2007
1	Endothelin-1 (Endothelin 1)IBA 06/2006
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 02/2006
1	Prazosin (Minipress)FDA LinkGeneric 02/2006
1	naftopidilIBA 02/2006
1	alfuzosin (UroXatral)FDA Link 02/2006
1	Terazosin (Hytrin)FDA LinkGeneric 02/2006
1	Doxazosin (Cardura)FDA LinkGeneric 02/2006
1	Pharmaceutical PreparationsIBA 04/2005
1	SaltsIBA 09/2004
1	Endothelin Receptor AntagonistsIBA 09/2004

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 06/2019 - 01/2018
1	Cesarean Section (Caesarean Section) 04/2020
1	Therapeutics 06/2019
1	Ligation 09/2006
1	Injections 02/2006
1	Oral Administration 06/2005